{
    "title": "114_s3209",
    "content": "The \"Prescription Drug Monitoring Act of 2016\" may be cited as the short title for this Act. It includes definitions for various terms used in the legislation. In this Act, \"controlled substance\" is defined as per the Controlled Substances Act. A \"covered State\" is one that receives funding under specific programs. A \"dispenser\" is a person authorized to deliver prescription drugs to a patient. The curr_chunk defines terms related to prescription drug monitoring programs, practitioners, and states. The curr_chunk focuses on the requirements for prescription drug monitoring programs. Beginning 2 years after enactment, covered States must require prescribing practitioners to consult the PDMP before initiating treatment with certain controlled substances and every 3 months thereafter. The PDMP must provide proactive notification of misuse patterns, and dispensers must report each. The covered State must report each prescription for a controlled substance dispensed to the PDMP within 24 hours. The PDMP must provide de-identified data sets and annual reports for public and private use. Noncompliance may result in withholding grant funds under the Harold Rogers Prescription Drug Monitoring Program. The Monitoring Program established under the Departments of Commerce, Justice, and State, the Judiciary, and Related Agencies Appropriations Act, 2002 or the controlled substance monitoring program under section 399O of the Public Health Service Act. SEC. 4. SHARING PDMP INFORMATION AMONG STATES. Beginning 2 years after enactment, covered States must share PDMP data with other States through a data-sharing technology solution. The Attorney General will award a grant to establish an inter-State data-sharing hub for this purpose, allowing States to retain ownership of their submitted data. The data submitted by States must be de-identified and accessible for statistical, research, or educational purposes. State authorized users can access PDMP data without a fee, following standards of the Prescription Monitoring Information Exchange. Distribution of PDMP data requires consent from the PDMP State authority and cannot be limited without approval. Authorization of $2,000,000 in appropriations for the Attorney General from 2017 to 2020 to distribute PDMP data approved by State authority."
}